ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000185203.7	ABT-263 (navitoclax)	Cervical squamouscell carcinoma and endocervical adenocarcinoma	0.008194669	Resistant
ENSG00000185203.7	ABT-263 (navitoclax)	Brain lower grade glioma	0.024007559	Sensitive